Burnaby company granted Health Canada licence to produce 'magic mushroom' medicine
Burnaby company granted Health Canada licence to produce 'magic mushroom' medicine
At Burnaby’s Albert Labs, it’s science meets nature. On the walls, you’ll find posters of various mushrooms next to scientific formulas, symbolizing the company's mission to develop mental health medicine derived from natural substances. The small team of around 20 employees recently received a Health Canada license to further pursue its work in producing psilocybin from mushrooms.
“Oh, it’s very big,” said Ali Gulamhusein, chief development officer for Albert Labs.
“That licence grants us the ability to produce, manufacture, export and import psilocybin.”
Gulamhusein refers to psilocybin as the magic medicine of the magic mushroom. The company also operates in the U.K. and Portugal, and plans to begin clinical trials in the U.K. this fall.
“(The) first early indications that we’re targeting is cancer-related anxiety,” said Gulamhusein, who adds that the company also hopes to treat people with depression, anxiety and PTSD.
Gulamhusein says the process involves isolating the psilocybin from the root and bio-engineering the drug in a controlled setting to help ensure consistency.
The company’s CEO says studies of the treatment have been overwhelmingly positive, calling psilocybin a potential game changer when it comes to mental illness therapy.
“One dose – and associated psychotherapy – cures anxiety for many months, and in some cases, permanently,” said Dr. Michael Raymont.
But it’s currently only available for Canadians with special permission from doctors. Christine Parlee lives with terminal stage four cancer and was granted permission for treatment to help ease her severe anxiety.
“It was phenomenal, probably one of the best experiences of my life to be honest,” said Parlee via Zoom from her home in Duncan.
“To say it changed me down to the bottom of my core is putting it mildly.”
One expert tells CTV News that despite high demand from patients, it could take two to three years before psychedelics become a common, more accessible treatment.
“I think there’s a lot of work to be done in training of professionals in understanding this new paradigm in mental health treatment,” said Dr. Devon Christie, senior lead of psychedelic programs at Numinus.
Meanwhile, if all goes well in the U.K., Albert Labs hopes to have its drug ready for trial in Canada by 2023.
CTVNews.ca Top Stories
BREAKING | Brown campaign accuses Conservative party of acting in favour of Poilievre after disqualification from leadership race
The campaign for Patrick Brown said it was consulting its legal team after the leadership election organizing committee of the federal Conservatives voted to disqualify him from the race late Tuesday.

Woman who was set on fire on Toronto bus has died, police confirm
A woman who was set on fire while on a Toronto bus in a random attack last month has died, police say.
Assembly of First Nations delegates reject resolution calling for chief's suspension
An emergency resolution before the Assembly of First Nations annual meeting to reaffirm the suspension of National Chief RoseAnne Archibald has failed in Vancouver.
'We're all really shaken up': Father recounts reuniting with missing daughter as U.S. man is charged
The father of the Edmonton girl who was missing for nine days said he was getting ready to post another update on Facebook last Saturday when police knocked on his door.
Two young ER doctors quit Montreal jobs, blaming Quebec's broken health-care system and Bill 96
Two young emergency room doctors, raised and trained in Montreal, are leaving their jobs after only two years to move back to Toronto – and they say the Quebec health-care model and Bill 96 are to blame.
Tamara Lich breached conditions by appearing with fellow convoy leader: Crown
The Crown is seeking to revoke bail for Tamara Lich, a leader of the 'Freedom Convoy,' after she appeared alongside a fellow organizer in an alleged breach of her conditions.
Parade shooting suspect charged with 7 counts of murder
A man charged Tuesday with seven counts of murder after firing off more than 70 rounds at an Independence Day parade in suburban Chicago legally bought five weapons, including the high-powered rifle used in the shooting, despite authorities being called to his home twice in 2019 for threats of violence and suicide, police said.
Bank of Canada's rapid rate hikes likely to cause a recession, study finds
The Bank of Canada's strategy of rapidly increasing its key interest rate in an effort to tackle skyrocketing inflation will likely trigger a recession, says a new study released Tuesday from the Canadian Centre for Policy Alternatives.
Canada is the first country to ratify Finland and Sweden's accession to join NATO
Canada became the first country to ratify Finland and Sweden's accession protocols to join the North Atlantic Treaty Organization (NATO), Prime Minister Justin Trudeau announced Tuesday.